Literature DB >> 26663188

microRNA and Kidney Transplantation.

Kíra Jelencsics1, Rainer Oberbauer2.   

Abstract

The kidney serves as the main clearance organ of our body, filtrating and excreting metabolic waste products. Various intrinsic and extrinsic conditions can lead to kidney injury, roughly 0.1% of the population suffer from end stage renal disease. Renal transplantation reinstitutes an almost normal quality of life; again it is cost effective and thus the preferred treatment of terminal renal failure. miRNAs play pivotal roles in immune responses and inflammation, which makes them particularly interesting in the field of transplantation and in understanding the molecular pathways of allograft pathologies such as delayed function or cellular and antibody mediated rejection. As kidney biopsy is part of the routine disease monitoring, the identification of miRNA pattern is feasible in different stages of the injury. Furthermore miRNAs are easy to detect not only in tissue samples but also in body fluids such as blood and urine. Their regulatory capacity of biological processes together with their stability makes them excellent candidates for noninvasive monitoring of kidney pathology. There is an accumulating knowledge about diseases-specific miRNA signatures in distinct kidney injuries. In the following chapter we present the current understanding of miRNAs regulation of intragraft processes after kidney transplantation.

Entities:  

Keywords:  Kidney; Pathology; Transplantation

Mesh:

Substances:

Year:  2015        PMID: 26663188     DOI: 10.1007/978-3-319-22671-2_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function.

Authors:  Sepideh Zununi Vahed; Ahmad Poursadegh Zonouzi; Hossein Ghanbarian; Morteza Ghojazadeh; Nasser Samadi; Yadollah Omidi; Mohammadreza Ardalan
Journal:  Int Urol Nephrol       Date:  2017-04-28       Impact factor: 2.370

2.  Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.

Authors:  Sean Agbor-Enoh; Ilker Tunc; Iwijn De Vlaminck; Ulgen Fideli; Andrew Davis; Karen Cuttin; Kenneth Bhatti; Argit Marishta; Michael A Solomon; Annette Jackson; Grace Graninger; Bonnie Harper; Helen Luikart; Jennifer Wylie; Xujing Wang; Gerald Berry; Charles Marboe; Kiran Khush; Jun Zhu; Hannah Valantine
Journal:  J Heart Lung Transplant       Date:  2017-05-20       Impact factor: 10.247

3.  Effect of miR-146a and miR-155 on cardiac xenotransplantation.

Authors:  Zhicheng Zhao; Feng Qi; Tong Liu; Weihua Fu
Journal:  Exp Ther Med       Date:  2016-11-03       Impact factor: 2.447

4.  Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype - Role of Risk Factors and Epigenetics.

Authors:  Timothy D Hewitson; Stephen G Holt; Edward R Smith
Journal:  Front Pharmacol       Date:  2017-08-08       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.